Legend Competitors

LEGN Stock

USD 65.34 1.96 3.09%

Legend BiotechCorp competes with Guangdong Investment, United Microelectronics, Black Hills, Sun Life, and Micron Technology; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Legend BiotechCorp competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Legend BiotechCorp to its intrinsic valuation because they are able to contrast its competitors on a relative basis.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Legend BiotechCorp competition on your existing holdings. Check out Legend BiotechCorp Correlation with its peers.To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.

As of 5th of June 2023, Return on Average Assets is likely to drop to -0.39. In addition to that, Return on Average Equity is likely to drop to -0.64. As of 5th of June 2023, Asset Turnover is likely to grow to 0.10, while Total Assets are likely to drop about 1.2 B.

Specify up to 10 symbols:

Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Legend BiotechCorp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Legend BiotechCorp in the context of predictive analytics.

Hype

Prediction

Low	Estimated	High
61.63	65.27	68.91

Details

Intrinsic

Valuation

Low	Real	High
57.04	74.85	78.49

Details

15 Analysts

Consensus

Low	Target	High
64.00	77.36	90.00

Details

Earnings

Estimates (6)

Low	Projected EPS	High
-0.78	-0.57	-0.36

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Legend BiotechCorp. Your research has to be compared to or analyzed against Legend BiotechCorp's peers to derive any actionable benefits. When done correctly, Legend BiotechCorp's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Legend BiotechCorp.

Legend BiotechCorp Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Legend BiotechCorp and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Legend and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Legend BiotechCorp does not affect the price movement of the other competitor.

Related Correlations

	GGDVF	UMC	BKH	SLF	MU	VSH	IGI	MRAM
GGDVF		0.31	-0.12	-0.52	-0.67	-0.74	0.13	-0.8	GGDVF
UMC	0.31		-0.48	-0.6	-0.23	-0.22	0.18	-0.21	UMC
BKH	-0.12	-0.48		0.37	0.15	-0.13	0.55	-0.13	BKH
SLF	-0.52	-0.6	0.37		0.56	0.51	-0.21	0.61	SLF
MU	-0.67	-0.23	0.15	0.56		0.78	0.0	0.74	MU
VSH	-0.74	-0.22	-0.13	0.51	0.78		-0.37	0.87	VSH
IGI	0.13	0.18	0.55	-0.21	0.0	-0.37		-0.36	IGI
MRAM	-0.8	-0.21	-0.13	0.61	0.74	0.87	-0.36		MRAM
	GGDVF	UMC	BKH	SLF	MU	VSH	IGI	MRAM

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Risk-Adjusted Indicators

Nowadays, there is a big difference between Legend Stock performing well and Legend BiotechCorp company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Legend BiotechCorp's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Information Ratio	Expected Shortfall	Potential Upside	Value At Risk	Maximum Drawdown
GGDVF	1.96	(0.20)	0.00	(0.26)	0.00	(0.05)	0.00	4.35	(7.07)	25.06	Guangdong Investment Profile Guangdong Investment Dashboard Technical analysis Backtest
UMC	1.35	0.03	0.02	0.02	1.56	0.0174	(1.56)	2.86	(2.41)	11.10	United Microelectronics Profile United Microelectronics Dashboard Technical analysis Backtest News Timeline Analyst Consensus Fundamentals Trends
BKH	0.97	0.05	0.05	0.07	1.05	0.0448	(1.09)	2.62	(1.80)	5.27	Black Hills Profile Black Hills Dashboard Technical analysis Backtest News Timeline Fundamentals Trends
SLF	0.87	0.07	0.06	0.06	1.17	0.06	(0.84)	2.20	(1.89)	4.77	Sun Life Profile Sun Life Dashboard Technical analysis Backtest News Timeline Analyst Consensus Fundamentals Trends
MU	2.13	0.33	0.16	0.34	1.84	0.12	(2.64)	6.11	(3.12)	12.91	Micron Technology Profile Micron Technology Dashboard Technical analysis Backtest News Timeline Analyst Consensus Fundamentals Trends
VSH	1.42	0.37	0.27	0.35	1.03	0.15	(1.80)	2.43	(1.63)	18.31	Vishay Intertechnology Profile Vishay Intertechnology Dashboard Technical analysis Backtest News Timeline Analyst Consensus Fundamentals Trends
IGI	0.55	0.00	0.02	(0.03)	0.71	0.0229	(0.56)	1.32	(1.06)	3.73	Western Asset Profile Western Asset Dashboard Technical analysis Backtest News Timeline
MRAM	2.02	0.34	0.15	0.57	1.92	0.13	(2.27)	5.72	(4.52)	11.94	Everspin Technologies Profile Everspin Technologies Dashboard Technical analysis Backtest News Timeline Analyst Consensus Fundamentals Trends

Cross Equities Net Income Analysis

Compare Legend BiotechCorp and related stocks such as Guangdong Investment, United Microelectronics, Black Hills, Sun Life Financial, Micron Technology, Vishay Intertechnology, Western Asset Investment, and Everspin Technologies Net Income Over Time

Select Fundamental

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

UMC

6.1 B

12.6 B

11.1 B

13.3 B

8.6 B

9.7 B

7.7 B

8.2 B

22.9 B

51.2 B

89.5 B

96.5 B

BKH

102.4 M

117.4 M

130.9 M

(32.1 M)

73 M

177 M

258.4 M

199.3 M

227.6 M

236.7 M

258.4 M

228.1 M

SLF

1.6 B

942 M

1.9 B

2.3 B

2.6 B

2.2 B

2.6 B

2.7 B

2.5 B

4 B

3.1 B

3 B

(276 M)

8.7 B

5.1 B

5.2 B

VSH

122.7 M

123 M

117.6 M

(108.5 M)

48.8 M

(20.3 M)

345.8 M

163.9 M

122.9 M

298 M

428.8 M

462.7 M

MRAM

(10.2 M)

(18.2 M)

(16.7 M)

(21.1 M)

(17.8 M)

(14.7 M)

(8.5 M)

4.3 M

6.1 M

6.6 M

Legend BiotechCorp and related stocks such as Guangdong Investment, United Microelectronics, Black Hills, Sun Life Financial, Micron Technology, Vishay Intertechnology, Western Asset Investment, and Everspin Technologies Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Legend BiotechCorp financial statement analysis. It represents the amount of money remaining after all of Legend BiotechCorp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income Available to Non-controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Legend BiotechCorp Competitive Analysis

The better you understand Legend BiotechCorp competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Legend BiotechCorp's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Legend BiotechCorp's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	LEGN	GGDVF	UMC	BKH	SLF	MU	VSH	IGI	MRAM
	3.09 65.34 Legend	5.75 0.82 Guangdong	1.80 8.17 United	0.0161 62.03 Black	0.16 50.15 Sun	0.0148 67.77 Micron	0.00 25.87 Vishay	0.00 16.32 Western	0.12 8.52 Everspin
Market Volatility (90 Days Market Risk)	Very steady	Extremely Dangerous	Not too volatile	Very steady	Very steady	Very steady	Very steady	Very steady	Somewhat reliable
Market Performance (90 Days Performance)	Good	Very Weak	Very Weak	Insignificant	Insignificant	OK	OK	Weak	Good
Odds of Financial Distress (Probability Of Bankruptcy)	Low	Very Low	Very Low	Below Average	Very Small	Very Low	Very Low	High	Very Low
Current Valuation (Equity Enterprise Value)	Under Valued	Over Valued	Fairly Valued	Fairly Valued	Fairly Valued	Under Valued	Fairly Valued	Over Valued	Under Valued
Buy or Sell Advice (Average Analysts Consensus)	Buy	Not Available	Hold	Sell	Hold	Buy	Hold	Not Available	Strong Buy
Trade Advice (90 Days Macroaxis Advice)	Strong Buy	Strong Sell	Strong Hold	Strong Hold	Strong Hold	Strong Buy	Strong Buy	Strong Sell	Buy
Number of Shares Shorted	4.68 M	N/A	51.02 M	1.23 M	7.28 M	26.27 M	6.07 M	659	113.15 K
Shares Owned by Insiders	1.42	56.61	N/A	0.62	0.07	0.28	0.64	N/A	4.16
Current Ratio	3.83	1.64	2.02	0.97	811.07	2.89	2.94	N/A	4.03
Net Asset	1.33 B	130.03 B	533.05 B	9.62 B	330.91 B	66.28 B	3.87 B	188.74 M	55.33 M
Profit Margin	N/A	0.18	0.31	0.0962	0.13	0.0699	0.12	N/A	0.0819
EBITDA	(437.44 M)	10.89 B	148.13 B	457 M	4.84 B	16.92 B	774.62 M	N/A	7.4 M
Operating Margin	-5.0	0.25	0.36	0.17	0.18	0.09	0.18	N/A	0.081
Current Valuation	8.02 B	10.05 B	13.75 B	9.2 B	25.71 B	57.74 B	2.82 B	N/A	98.59 M
Cash Flow from Operations	(200.03 M)	(4.94 B)	145.86 B	584.8 M	4.31 B	15.18 B	484.29 M	N/A	9.49 M
Five Year Return	N/A	4.01	3.85	3.17	3.72	0.34	1.81	4.55	N/A
Retained Earnings	N/A	N/A	175.77 B	1.06 B	16.81 B	47.27 B	773.23 M	(19.65 M)	(146.7 M)
Current Asset	N/A	N/A	94.82 B	822.15 M	N/A	9.49 B	1.89 B	N/A	25.31 M
Beta	-0.0584	0.51	1.31	0.58	0.98	1.41	1.31	0.12	1.3
Price to Book	19.8	1.09	1.76	1.59	1.37	1.19	1.67	0.9	3.05
Shares Outstanding	180.35 M	6.54 B	2.5 B	66.66 M	586.75 M	1.09 B	127.58 M	10.85 M	20.62 M
Annual Yield	N/A	0.0679	0.0605	0.0413	0.0451	0.0067	0.0154	0.0488	N/A
Total Debt	260.93 M	21.81 B	45.08 B	3.61 B	12.88 B	6.8 B	500.94 M	N/A	1.53 M
Return On Equity	-0.96	0.0954	0.26	0.0867	0.13	0.0339	0.22	N/A	0.14
Price to Earning	N/A	9.97	13.43	19.38	14.03	19.6	25.97	89.0	12.89
Z Score	26.01	N/A	2.51	0.98	1.56	9.24	6.72	-0.15	67.72
Shares Owned by Institutions	39.26	18.88	5.41	91.56	53.57	84.2	95.96	44.66	54.76
Return On Asset	-0.29	0.0386	0.12	0.0307	0.0085	0.0199	0.1	N/A	0.0644
Book Value Per Share	3.95	6.81	142.03	46.5	35.86	43.2	15.34	N/A	1.98
Cash and Equivalents	791.26 M	10.53 B	131.39 B	21.43 M	6.31 B	9.33 B	610.83 M	N/A	23.44 M
Price to Earnings To Growth	N/A	N/A	1.43	3.27	0.94	1.12	0.75	N/A	-0.6
Current Liabilities	N/A	N/A	49.49 B	422.03 M	N/A	4.83 B	457.72 M	N/A	10.64 M
Total Asset	1.33 B	130.03 B	533.05 B	9.62 B	330.91 B	66.28 B	3.87 B	188.74 M	55.33 M
Short Ratio	3.7	N/A	8.2	3.52	15.2	1.87	5.03	0.04	1.95
Target Price	80.9	N/A	7.62	66.43	56.05	69.14	24.33	N/A	10.0
Last Dividend Paid	N/A	0.61	3.6	2.44	2.82	0.46	0.4	N/A	N/A
Price to Sales	73.18	0.27	0.0651	1.93	1.12	1.85	0.88	81.16	1.76
Market Capitalization	11.43 B	7.52 B	21.33 B	4.15 B	29.45 B	75.7 B	3.71 B	177.36 M	176.27 M
Cash per Share	5.11	1.61	76.31	0.16	141.27	8.58	5.93	N/A	1.15
Net Income	(445.72 M)	4.7 B	106.1 B	270.76 M	3.92 B	8.69 B	430.48 M	N/A	6.13 M
Earnings Per Share	-3.26	0.1	1.12	4.0	4.11	1.43	3.13	-3.44	0.24
Debt to Equity	0.29	0.69	0.23	1.5	0.31	0.15	0.31	N/A	0.28
Revenue	117 M	29.72 B	278.71 B	458.5 M	23.21 B	30.76 B	3.5 B	N/A	59.98 M
Working Capital	801.33 M	N/A	143.81 B	(594.98 M)	N/A	14.24 B	1.39 B	N/A	33.87 M
Gross Profit	(284.01 M)	11.64 B	125.76 B	772.84 M	14.48 B	13.9 B	1.07 B	N/A	33.95 M
Day Typical Price	64.08	N/A	8.18	62.09	50.1	68.26	25.94	16.31	8.55
Accumulation Distribution	55813.67	N/A	55356.87	7079.46	4146.97	356062.0	6715.39	195.51	1202.46
Market Facilitation Index	0.0	N/A	N/A	0.0	0.0	N/A	0.0	0.0	0.0
Daily Balance Of Power	0.4949	N/A	(1.25)	(0.007463)	(0.19)	(0.005025)	N/A	N/A	0.0769
Rate Of Daily Change	1.03	N/A	0.98	1.0	1.0	1.0	1.0	1.0	1.0
Day Median Price	63.45	N/A	8.18	62.12	50.08	68.51	25.98	16.31	8.57
Price Action Indicator	2.87	N/A	(0.09)	(0.1)	0.03	(0.74)	(0.10)	0.01	(0.04)
Coefficient Of Variation	703.49	(1,793)	6666.48	2432.97	1688.81	855.04	694.36	6069.81	785.07
Mean Deviation	2.34	1.96	1.35	0.9716	0.8692	2.13	1.42	0.5495	2.02
Jensen Alpha	0.5067	(0.20)	0.032	0.0498	0.0735	0.3286	0.3658	8.0E-4	0.3418
Total Risk Alpha	0.5541	(0.16)	0.0479	0.0602	0.076	0.3584	0.3899	0.013	0.375
Sortino Ratio	0.2469	N/A	0.0198	0.0511	0.0572	0.1593	0.2729	0.0219	0.1497
Downside Variance	4.32	N/A	2.78	1.18	1.62	4.28	1.79	0.562	5.4
Standard Deviation	3.58	3.64	1.9	1.24	1.15	2.78	2.51	0.7185	2.69
Kurtosis	11.89	4.64	3.88	0.0293	0.5133	0.4494	28.31	0.5503	0.6531
Potential Upside	5.27	4.35	2.86	2.62	2.2	6.11	2.43	1.32	5.72
Treynor Ratio	0.8933	(0.26)	0.0199	0.0677	0.0554	0.3437	0.3469	(0.026255)	0.57
Maximum Drawdown	23.82	25.06	11.1	5.27	4.77	12.91	18.31	3.73	11.94
Variance	12.8	13.23	3.61	1.54	1.33	7.73	6.28	0.5163	7.26
Market Risk Adjusted Performance	0.9033	(0.25)	0.0299	0.0777	0.0654	0.3537	0.3569	(0.016255)	0.58
Risk Adjusted Performance	0.1412	(0.045087)	0.0192	0.0411	0.0576	0.1167	0.1418	0.0124	0.1264
Skewness	2.64	(0.77)	1.16	0.552	(0.19)	0.8132	4.39	0.028	0.5081
Semi Deviation	1.81	N/A	1.56	1.05	1.17	1.84	1.03	0.7051	1.92
Information Ratio	0.1434	(0.05)	0.0174	0.0448	0.0632	0.1186	0.1459	0.0229	0.1291
Value At Risk	(3.38)	(7.07)	(2.41)	(1.80)	(1.89)	(3.12)	(1.63)	(1.06)	(4.52)
Expected Short fall	(3.15)	N/A	(1.56)	(1.09)	(0.84)	(2.64)	(1.80)	(0.56)	(2.27)
Downside Deviation	2.08	N/A	1.67	1.09	1.27	2.07	1.34	0.7497	2.32
Semi Variance	3.27	N/A	2.44	1.09	1.38	3.4	1.05	0.4971	3.67

Legend BiotechCorp Competition Performance Charts

Five steps to successful analysis of Legend BiotechCorp Competition

Legend BiotechCorp's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Legend BiotechCorp in relation to its competition. Legend BiotechCorp's competition analysis typically involves several steps, including::

Identifying the key players in the market: This involves identifying the major competitors of Legend BiotechCorp in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Legend BiotechCorp's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Legend BiotechCorp, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Legend BiotechCorp position

In addition to having Legend BiotechCorp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Commodities Thematic Idea Now

Commodities

Funds or Etfs investing in commodities such as oil, gold, corn, soy, and agricultural goods. The Commodities theme has 37 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Commodities Theme or any other thematic opportunities.

View All Next

Launch

Check out Legend BiotechCorp Correlation with its peers.To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide. Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Legend Stock analysis

When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.

	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Bond Directory Find actively traded corporate debentures issued by US companies
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency

Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.26)

Revenue Per Share

0.639

Quarterly Revenue Growth

(0.12)

Return On Assets

(0.29)

Return On Equity

(0.96)

The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC

Working Capital	Tangible Assets Book Value per Share
Tangible Asset Value	Sales per Share
Return on Sales	Return on Invested Capital
Return on Average Equity	Return on Average Assets
Price to Sales Ratio	Price Sales Damodaran Method
Price to Earnings Ratio	Price Earnings Damodaran Method
Price to Book Value	Payout Ratio
Profit Margin	Market Capitalization
Invested Capital Average	Invested Capital
Gross Margin	Foreign Currency to USD Exchange Rate
Free Cash Flow per Share	Free Cash Flow
Enterprise Value over EBITDA	Enterprise Value over EBIT
Enterprise Value	Average Equity
Earnings per Basic Share USD	Earnings per Diluted Share
Earnings per Basic Share	Earnings before Tax
Earnings Before Interest Taxes and Depreciation Amortization USD	EBITDA Margin
Earnings Before Interest Taxes and Depreciation Amortization EBITDA	Dividends per Basic Common Share
Dividend Yield	Debt to Equity Ratio
Current Ratio	Book Value per Share
Asset Turnover	Average Assets
Total Assets Per Share	Net Assets Per Share
Cash Flow Per Share	Revenue Per Employee
Net Income Per Employee	Return on Investment
Operating Margin	Calculated Tax Rate
Receivables Turnover	Inventory Turnover
PPandE Turnover	Cash and Equivalents Turnover
Accounts Payable Turnover	Accrued Expenses Turnover
Interest Coverage	Long Term Debt to Equity
Quick Ratio	Net Current Assets as percentage of Total Assets
Revenue to Assets

Legend Competitors

Specify up to 10 symbols:

Legend BiotechCorp Competition Correlation Matrix

Related Correlations

Risk-Adjusted Indicators

Cross Equities Net Income Analysis

Legend BiotechCorp and related stocks such as Guangdong Investment, United Microelectronics, Black Hills, Sun Life Financial, Micron Technology, Vishay Intertechnology, Western Asset Investment, and Everspin Technologies Net Income description

Legend BiotechCorp Competitive Analysis

Legend BiotechCorp Competition Performance Charts

Five steps to successful analysis of Legend BiotechCorp Competition

Complement your Legend BiotechCorp position

Did You Try This Idea?

Run Commodities Thematic Idea Now

Commodities

Complementary Tools for Legend Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY